PlainRecalls
FDA Drug Moderate Class II Terminated

AvKARE Valsartan and Hydrochlorothiazide 80 mg/12.5 mg tablets, 90-count bottle, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 42291-884-90

Reported: September 12, 2018 Initiated: July 18, 2018 #D-1173-2018

Product Description

AvKARE Valsartan and Hydrochlorothiazide 80 mg/12.5 mg tablets, 90-count bottle, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 42291-884-90

Reason for Recall

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Details

Recalling Firm
Avkare Incorporated
Units Affected
12240 bottles
Distribution
Nationwide
Location
Pulaski, TN

Frequently Asked Questions

What product was recalled?
AvKARE Valsartan and Hydrochlorothiazide 80 mg/12.5 mg tablets, 90-count bottle, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 42291-884-90. Recalled by Avkare Incorporated. Units affected: 12240 bottles.
Why was this product recalled?
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 12, 2018. Severity: Moderate. Recall number: D-1173-2018.